Hearing Loss, Hearing Aids, and Cognition
This cohort study examines cognitive function in middle-aged adults with hearing loss, both with and without use of hearing aids.
Related Articles
What Donald Trump’s Win Means For AI
Following a historic victory at the polls, what will a second Trump term mean for America’s AI future?
The science stories likely to make the biggest headlines in 2025
Trump’s shakeups, risks from avian flu, and peak carbon emissions could produce big stories
Knowledge and Worry Following Review of Standard vs Patient-Centered Pathology Reports
This study compares knowledge of diagnosis and worry among adults presented with prostate biopsy reports in a patient-centered format, which present important clinical data in…
Lipoprotein a Testing Patterns in the Veterans Health Administration
This cross-sectional study evaluates contemporary patterns of lipoprotein a testing among US veterans receiving care through the Veterans Health Administration.
A Whole-Brain Phenomenon: New Research Challenges Old Theories of Intelligence
A new study shows that intelligence is best predicted by global brain connectivity, not just specific regions, indicating a more holistic neural basis for cognition.…
Prevalence of Dementia Among US Adults With Autism Spectrum Disorder
This cohort study evaluates the prevalence of dementia diagnoses among US adults with autism spectrum disorder.
High-Speed Robot Hand
Ishikawa Komuro Lab’s high-speed robot hand performing impressive acts of dexterity and skillful manipulation. For more information, see Hizook.com — http:…
Science Visuals team picks its favorite stories of the year
Team members describe what went into making and publishing 2024’s most engaging images and multimedia
Editor’s Corner—Fierce Health Payer’s top 10 stories of 2024
The past year has been a complicated one for health insurers, and our top stories of the year reflect the headwinds many companies faced and…
Cost-Effectiveness of Breast Cancer Screening Using Digital Mammography in Canada
This economic evaluation examines the cost-effectiveness of digital mammographic screening for breast cancer in the context of current treatment standards in Canada.